We provide you with 20 years of free, institutional-grade data for EOLS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EOLS. Explore the full financial landscape of EOLS stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-05 | 1570562 | EOLS | 10-Q | Url |
| 2025-05-07 | 1570562 | EOLS | 10-Q | Url |
| 2025-03-04 | 1570562 | EOLS | 10-K | Url |
| 2024-11-06 | 1570562 | EOLS | 10-Q | Url |
| 2024-07-31 | 1570562 | EOLS | 10-Q | Url |
| 2024-05-07 | 1570562 | EOLS | 10-Q | Url |
| 2024-03-07 | 1570562 | EOLS | 10-K | Url |
| 2023-11-07 | 1570562 | EOLS | 10-Q | Url |
| 2023-08-02 | 1570562 | EOLS | 10-Q | Url |
| 2023-05-09 | 1570562 | EOLS | 10-Q | Url |
| 2023-03-08 | 1570562 | EOLS | 10-K | Url |
| 2022-11-08 | 1570562 | EOLS | 10-Q | Url |
| 2022-08-02 | 1570562 | EOLS | 10-Q | Url |
| 2022-05-10 | 1570562 | EOLS | 10-Q | Url |
| 2022-03-03 | 1570562 | EOLS | 10-K | Url |
| 2021-11-02 | 1570562 | EOLS | 10-Q | Url |
| 2021-08-04 | 1570562 | EOLS | 10-Q | Url |
| 2021-05-12 | 1570562 | EOLS | 10-Q | Url |
| 2021-03-25 | 1570562 | EOLS | 10-K | Url |
| 2020-10-29 | 1570562 | EOLS | 10-Q | Url |
| 2020-08-10 | 1570562 | EOLS | 10-Q | Url |
| 2020-05-11 | 1570562 | EOLS | 10-Q | Url |
| 2020-02-25 | 1570562 | EOLS | 10-K | Url |
| 2019-11-04 | 1570562 | EOLS | 10-Q | Url |
| 2019-08-12 | 1570562 | EOLS | 10-Q | Url |
| 2019-05-01 | 1570562 | EOLS | 10-Q | Url |
| 2019-03-20 | 1570562 | EOLS | 10-K | Url |
| 2018-11-05 | 1570562 | EOLS | 10-Q | Url |
| 2018-08-02 | 1570562 | EOLS | 10-Q | Url |
| 2018-07-16 | 1570562 | EOLS | S-1 | Url |
| 2018-05-10 | 1570562 | EOLS | 10-Q | Url |
| 2018-03-29 | 1570562 | EOLS | 10-K | Url |
| 2018-01-09 | 1570562 | EOLS | S-1 | Url |
Evolus, Inc(NASDAQ:EOLS) 
Evolus, Inc., a performance beauty company, provides products in the self-pay aesthetic healthcare market for physicians and their patients in the United States. The company offers products for physicians that are sold to consumers or used in procedures for aesthetic indications, which are not reimb...
Website: http://www.evolus.com
Founded: 2012
Full Time Employees: 125
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about EOLS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.